Guidelines published by a government panel earlier this week, calling for aggressive use of Statin Medications to lower cholesterol in people at high risk of heart attacks, failed to list panelists' links to pharmaceutical companies, many of which manufacture Statin drugs.
Drug panelists links are under scrutiny.